Optimizing the Use of Novel Therapies for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) — September 23, 2026, St Louis, MO

A CME/MOC-Accredited Interactive Grand Rounds Series

Date
Wednesday, September 23, 2026

Program Schedule — Central Time
11:30 AM – 12:00 PM — Registration and Lunch
12:00 PM – 1:00 PM — Educational Program

Location
SLUCare Physician Group
3655 Vista Ave
West Pavilion, 3rd Fl
St Louis, MO 63110

Meeting Room
Petruska Conference Room

Jason Westin

Faculty

Jason Westin

MD, MS, FACP, FASCO

The University of Texas MD Anderson Cancer Center, Houston, Texas

Director, Lymphoma Clinical Research, Lead, Lymphoma and Myeloma Service Line, Professor, Department of Lymphoma and Myeloma

Registration

These activities are supported by educational grants from ADC Therapeutics, AstraZeneca Pharmaceuticals LP, Genentech, a member of the Roche Group, and Pfizer Inc.